Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results
Interim results of a Phase 1b trial of cirmtuz umab and paclitaxel in locally advanced/unresectable or metastatic HER2-negative breast...
Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results
Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
Equillium Announces Three Abstracts Accepted for Presentation at the 104th AAI Annual Meeting
MatriSys Bioscience Names Joyce Rico as Chief Medical Officer
ALASTIN Skincare® Named to Forbes America’s Best Startup Employers 2021 List